Interestingly, with the previously reported cutoff value of 38 for the sFlt‐1/PlGF ratio and 4‐week observation window, only 15 recruited subjects developed preeclampsia in our study, which was 30.5% (15/49) of the total preeclampsia‐positive patients (Table S5). The gene discussed is PGF; the disease is preeclampsia.